MedPath

Minimally Invasive Closure of Umbilical Hernias

Not Applicable
Terminated
Conditions
Umbilical Hernia
Interventions
Device: Deflux
Registration Number
NCT00706329
Lead Sponsor
South Shore Hospital
Brief Summary

The purpose of the study is to test the use of "Deflux" injections in a minimally invasive closure of umbilical (belly button) hernias in infants between birth and five years. The study is designed to demonstrate that the use of this device can safely and effectively close an umbilical hernia.

Detailed Description

All patients will undergo general anesthesia for their primary procedure, i.e. inguinal hernia repair. Once under general anesthesia, the abdomen will be prepped and draped in the usual sterile surgical fashion. The edge of the umbilical hernia defect will be palpated and in case there are any contents of the hernia present, they will be pushed into the abdominal cavity. Adequate relaxation, again, will be assured. A 24 gauge needle will be used to inject 1cc of Deflux ("Study Product") into each quadrant at the junction between the preperitoneal space and the inner palpable rim of the fascial defect. The surgeon's index finger stays in the center of the hernia defect, protecting the hernia sac contents from re-herniating. Closure of the umbilical defect will be confirmed by palpation immediately after injection. A sterile wound dressing will be applied and the primary surgical procedure will be performed afterwards.

Definition of Primary and Secondary Outcomes/Endpoints:

The endpoint of this study is closure of the umbilical hernia.

Data Collection Methods, Assessments, and Schedule (what assessments performed, how often): A data collection file is started at the time of enrollment in the study. Data collection includes patient age, gender, and weight at the time of operation, inner diameter of the umbilical hernia defect at the time of operation, description of the immediate postoperative results and follow-up exams at two weeks, one month, and six months.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Age 1-5 years
  • Umbilical hernia>1cm. diameter.
  • Undergoing either a general surgical or urologic procedure under general anesthesia other than umbilical hernia repair.
  • No previous umbilical hernia repair.
Exclusion Criteria
  • Over 5 years
  • No umbilical hernia
  • No other surgery required
  • Previous umbilical hernia repair

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DefluxDefluxTreatment with Deflux.
Primary Outcome Measures
NameTimeMethod
Close Belly Button or Umbilical HerniaAfter surgery, subjects will be followed at intervals of one month and six months from date of surgery.

The study was terminated prematurely by the IRB. Results are not shared due to data integrity concerns. These concerns are outlined in an FDA warning letter.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's Hospital Boston and South Shore Hospital

🇺🇸

South Weymouth, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath